HE, B. (2012). Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients. Dove Medical Press.
Cita Chicago Style (17a ed.)HE, Bays. Long-term (52–78 Weeks) Treatment with Colesevelam HCl Added to Metformin Therapy in Type 2 Diabetes Mellitus Patients. Dove Medical Press, 2012.
Cita MLA (8a ed.)HE, Bays. Long-term (52–78 Weeks) Treatment with Colesevelam HCl Added to Metformin Therapy in Type 2 Diabetes Mellitus Patients. Dove Medical Press, 2012.
Precaución: Estas citas no son 100% exactas.